(HealthDay News) — Nearly 10% of US medical visits took place via telehealth in 2021, according to a survey published in the Annals of Internal Medicine. Researchers described telehealth use using the ...
The FDA has approved Breyanzi (lisocabtagene maraleucel) to treat adults with relapsed or refractory mantle cell lymphoma.
Patients in the standard intervention group received care from 1 of 4 oncologists and 3 advance practice practitioners who underwent 3 hours of standardized Serious Illness Care Program (SICP) ...
From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums.
Integrating pharmacies into community oncology practices does not have much impact on cancer care, a new study suggests.
The FDA has granted accelerated approval to Retevmo (selpercatinib) for the treatment of pediatric patients 2 years of age and older.
Ancient Egyptians may have conducted medical explorations in patients with cancer or tried experimental treatments for cancer, evidence suggests.
(HealthDay News) — A new tool can measure sexual health in female partners of patients with prostate cancer, according to a study published in European Urology Oncology.
Donepezil does not improve cognitive function among breast cancer survivors who were exposed to chemotherapy, data suggest.
Gender, political affiliation, and health status are all associated with mistrust in the FDA, a survey suggests.
More than half of cancer survivors did not visit their primary care provider regularly in the 5 to 7 years after cancer diagnosis.
Patients living outside a cancer center's main catchment area have higher odds of being diagnosed with late-stage cancer, a study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results